https://doi.org/10.7490/f1000research.1116203.1
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
145
 
downloads
11
CITE
How to cite this poster:
Giangreco N and Tatonetti N. Using precision pharmacoviglance to detect developmentally-regulated adverse drug reactions: a case study with antiepileptic drugs [version 1; not peer reviewed]. F1000Research 2018, 7:1635 (poster) (https://doi.org/10.7490/f1000research.1116203.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Using precision pharmacoviglance to detect developmentally-regulated adverse drug reactions: a case study with antiepileptic drugs

Nicholas Giangreco1, Nicholas Tatonetti
Author Affiliations
  • Metrics
  • 145 Views
  • 11 Downloads
Browse by related subjects
Published 11 Oct 2018

Using precision pharmacoviglance to detect developmentally-regulated adverse drug reactions: a case study with antiepileptic drugs

[version 1; not peer reviewed]

Nicholas Giangreco1, Nicholas Tatonetti
Author Affiliations
1 Columbia University Medical Center, USA
Presented at
Observational Health Data Science and Informatics (OHDSI) Symposium 2018
Competing Interests

No competing interests were disclosed

Keywords
Pharmacovigilance, pediatric, reproducible-research
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.